Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LLRHNet: Multiple Lesions Segmentation Using Local-Long Range Features. | Front Neuroinform | 2022 | 35600503 | PubTator, text mining | PubMed |
| Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk. | Nat Genet | 2022 | 35590109 | PubTator, text mining | PubMed |
| Integrating single-cell RNA sequencing with spatial transcriptomics reveals immune landscape for interstitial cystitis. | Signal Transduct Target Ther | 2022 | 35589692 | PubTator, text mining | PubMed |
| Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy. | Invest Ophthalmol Vis Sci | 2022 | 35579905 | PubTator, text mining | PubMed |
| Dynamic human liver proteome atlas reveals functional insights into disease pathways. | Mol Syst Biol | 2022 | 35579278 | PubTator, text mining | PubMed |
| Spatiotemporal Mapping of Efficient Chiral Induction by Helicene-Type Additives in Copolymer Thin Films. | Angew Chem Int Ed Engl | 2022 | 35577763 | PubTator, text mining | PubMed |
| An Optimized Tissue Dissociation Protocol for Single-Cell RNA Sequencing Analysis of Fresh and Cultured Human Skin Biopsies. | Front Cell Dev Biol | 2022 | 35573685 | PubTator, text mining | PubMed |
| Aqueous Lumican Correlates with Central Retinal Thickness in Patients with Idiopathic Epiretinal Membrane: A Proteome Study. | Dis Markers | 2022 | 35571611 | PubTator, text mining | PubMed |
| Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer. | BMC Cancer | 2022 | 35568835 | PubTator, text mining | PubMed |
| Increased Complement-Associated Inflammation in Cytomegalovirus-Positive Hypertensive Anterior Uveitis Patients Based on the Aqueous Humor Proteomics Analysis. | J Clin Med | 2022 | 35566463 | PubTator, text mining | PubMed |
| Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. | Cancers (Basel) | 2022 | 35565419 | PubTator, text mining | PubMed |
| Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts. | Cancers (Basel) | 2022 | 35565326 | PubTator, text mining | PubMed |
| Unraveling the Molecular Basis of the Dystrophic Process in Limb-Girdle Muscular Dystrophy LGMD-R12 by Differential Gene Expression Profiles in Diseased and Healthy Muscles. | Cells | 2022 | 35563815 | PubTator, text mining | PubMed |
| Transcriptomic and Proteomic Analysis of CRISPR/Cas9-Mediated ARC-Knockout HEK293 Cells. | Int J Mol Sci | 2022 | 35562887 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35557945 | PubTator, text mining | PubMed |
| Epicardium-derived cells organize through tight junctions to replenish cardiac muscle in salamanders. | Nat Cell Biol | 2022 | 35550612 | PubTator, text mining | PubMed |
| In vivo fate and intracellular trafficking of vaccine delivery systems. | Adv Drug Deliv Rev | 2022 | 35550392 | PubTator, text mining | PubMed |
| Cellular Heterogeneity of the Heart. | Front Cardiovasc Med | 2022 | 35548426 | PubTator, text mining | PubMed |
| NR4A Family Genes: A Review of Comprehensive Prognostic and Gene Expression Profile Analysis in Breast Cancer. | Front Oncol | 2022 | 35547878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=52